Inhibition of lnc‐COL6A1‐6‐Alleviated Osteogenic Differentiation of Valvular Interstitial Cells During Aortic Valve Calcification
Cardiovascular Therapeutics · 2025-01 · 2025 (1)
DOI: 10.1155/cdr/2277191 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Therapeutics, online erschienen am 03.09.2025. Verfasst von Ying Gu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Aortic Valve, RNA, Long Noncoding, Calcinosis, Osteogenesis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Research and Development Projects of Shaanxi Province, Science and Technology Innovation Plan Of Shanghai Science and Technology Commission, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Calcific aortic valve disease (CAVD) is a prevalent valvular heart disease characterized by the fibrocalcific remodeling of the aortic valves, leading to significant health issues among the elderly population worldwide. The aberrant expression of long noncoding RNAs (lncRNAs) is closely associated with the pathogenesis of various diseases. Methods and Results: A total of 241 differentially expressed lncRNAs were identified in calcified aortic valve tissues (fold change of ≥ 2 and p value < 0.05), including 65 upregulated and 176 downregulated lncRNAs. The expression of the Top 5 upregulated lncRNAs was monitored during the calcification of valvular interstitial cell (VIC). Notably, the expression of lnc‐PRDM8‐3 and lnc‐COL6A1‐6 in VICs increased significantly after calcification induction and was sustained at high levels. Inhibition of lnc‐COL6A1‐6, but not lnc‐PRDM8‐3, obviously alleviated the calcification of VICs, as evidenced by a marked reduction in calcium deposition, decreased alkaline phosphatase activity, and downregulated expression of Runx2 and OPN. Bioinformatic analysis predicted that lnc‐COL6A1‐6 might serve as a competing endogenous RNA for 11 miRNAs, potentially regulating the expression of 784 target genes. Among these, the Top 50 target genes were found to be significantly enriched in autophagy‐related biological processes. Consistently, elevated levels of the autophagic markers Beclin 1 and LC3 β were detected in calcified aortic valve tissues. Inhibition of lnc‐COL6A1‐6 significantly reduced autophagic flux in VICs under calcification‐inducing conditions. Importantly, pharmacological inhibition of autophagy using chloroquine abolished the anticalcific effects of lnc‐COL6A1‐6 knockdown.
Conclusions
The present study identified a lnc‐COL6A1‐6‐mediated miRNA–mRNA regulatory network in aortic valve calcification. Knockdown of lnc‐COL6A1‐6 could mitigate VIC calcification by attenuating autophagic activity, highlighting its potential as a therapeutic target for CAVD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu, China.
- Department of Cardiovascular Surgery, Changhai Hospital, Naval Medical University, Shanghai, China.
- Department of Cardiothoracic Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China.
- Department of Respiratory and Critical Care Medicine, Tangdu Hospital, Air Force Medical University, Xi'an, Shaanxi, China.
ORCID-Profile: Ying Gu, Fan Yang, Quangong Zhao, Jingwen Zhou, Xiangyang Xu, Yang Yuan, Xian Guo, Zhigang Song, Zhiyun Xu, Guokun Wang
Förderung
- Key Research and Development Projects of Shaanxi Province
- Science and Technology Innovation Plan Of Shanghai Science and Technology Commission
- National Natural Science Foundation of China
Zitieren
APA
Gu, Y., Yang, F., Zhao, Q., Zhou, J., Xu, X., Yuan, Y., Guo, X., Song, Z., Xu, Z., & Wang, G. (2025). Inhibition of lnc‐COL6A1‐6‐Alleviated Osteogenic Differentiation of Valvular Interstitial Cells During Aortic Valve Calcification. Cardiovascular Therapeutics, 2025(1). https://doi.org/10.1155/cdr/2277191
Vancouver
Gu Y, Yang F, Zhao Q, Zhou J, Xu X, Yuan Y, et al. Inhibition of lnc‐COL6A1‐6‐Alleviated Osteogenic Differentiation of Valvular Interstitial Cells During Aortic Valve Calcification. Cardiovascular Therapeutics. 2025;2025(1). doi:10.1155/cdr/2277191
BibTeX
@article{Gu2025,
author = {Gu, Ying and Yang, Fan and Zhao, Quangong and Zhou, Jingwen and Xu, Xiangyang and Yuan, Yang and Guo, Xian and Song, Zhigang and Xu, Zhiyun and Wang, Guokun},
title = {Inhibition of lnc‐COL6A1‐6‐Alleviated Osteogenic Differentiation of Valvular Interstitial Cells During Aortic Valve Calcification},
journal = {Cardiovascular Therapeutics},
year = {2025},
volume = {2025},
number = {1},
doi = {10.1155/cdr/2277191}
}
EUVIMED